Entrada Therapeutics (TRDA) files $400M mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St futures steady with focus on Mideast talks, US-China summit
- Activist Jana Partners calls for Six Flags sale - WSJ
- Oil holds near two-week lows while diesel cracks hit record peak
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
Form S-3 Entrada Therapeutics,
November 6, 2025 7:41 AM EST
As filed with the Securities and Exchange Commission on November 6, 2025
Registration No. 333-
... More